Busca un médico

Jane H. Cerhan, Ph.D., L.P.

  1. Psychologist

Publicaciones

  1. Wefel JS, Deshmukh S, Brown PD, Grosshans DR, Sulman EP, Cerhan JH, Mehta MP, Khuntia D, Shi W, Mishra MV, Suh JH, Laack NN, Chen Y, Curtis AA, Laba JM, Elsayed A, Thakrar A, Pugh SL, Bruner DW. Impact of Apolipoprotein E Genotype on Neurocognitive Function in Patients With Brain Metastases: An Analysis of NRG Oncology's RTOG 0614. Int J Radiat Oncol Biol Phys. 2024 Jul 1; 119 (3):846-857 Epub 2023 Dec 13
    View PubMed
  2. Beyer J, Couch R, Ruddy KJ, Zeydan B, Tosakulwong N, Lesnick TG, Novotny PJ, Kohli S, Cerhan JH, Pruthi S, Kantarci K, Kara F. Longitudinal cognitive function and brain metabolites in women receiving chemotherapy for stage 1 to 3 breast cancer: Observational study. Medicine (Baltimore). 2023 Oct 20; 102 (42):e35524
    View PubMed
  3. Wittwer ED, Cerhan JH, Schroeder DR, Schaff HV, Mauermann WJ. Impact of ketamine versus propofol for anesthetic induction on cognitive dysfunction, delirium, and acute kidney injury following cardiac surgery in elderly, high-risk patients. Ann Card Anaesth. 2023 Jul-Sep; 26 (3):274-280
    View PubMed
  4. Huntoon K, Anderson SK, Ballman KV, Twohy E, Dooley K, Jiang W, An Y, Li J, von Roemeling C, Qie Y, Ross OA, Cerhan JH, Whitton AC, Greenspoon JN, Parney IF, Ashman JB, Bahary JP, Hadjipanayis C, Urbanic JJ, Farace E, Khuntia D, Laack NN, Brown PD, Roberge D, Kim BYS. Association of circulating markers with cognitive decline after radiation therapy for brain metastasis. Neuro Oncol. 2023 Jun 2; 25 (6):1123-1131
    View PubMed
  5. Palmer JD, Klamer BG, Ballman KV, Brown PD, Cerhan JH, Anderson SK, Carrero XW, Whitton AC, Greenspoon J, Parney IF, Laack NNI, Ashman JB, Bahary JP, Hadjipanayis CG, Urbanic JJ, Barker FG 2nd, Farace E, Khuntia D, Giannini C, Buckner JC, Galanis E, Roberge D. Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis: A Secondary Analysis of The N107C/CEC.3 (Alliance for Clinical Trials in Oncology/Canadian Cancer Trials Group) Randomized Clinical Trial. JAMA Oncol. 2022 Dec 1; 8 (12):1809-1815
    View PubMed
  6. Porter AB, Liu H, Kohli S, Cerhan JL, Sloan J, McMurray RP, Le-Rademacher J, Loprinzi CL, Villano JL, Kizilbash SH, Mehta MP, Jaeckle KA, Brown PD. Efficacy of Treatment With Armodafinil for Cancer-Related Fatigue in Patients With High-grade Glioma: A Phase 3 Randomized Clinical Trial. JAMA Oncol. 2022 Feb 1; 8 (2):259-267
    View PubMed
  7. Jaeckle KA, Ballman KV, van den Bent M, Giannini C, Galanis E, Brown PD, Jenkins RB, Cairncross JG, Wick W, Weller M, Aldape KD, Dixon JG, Anderson SK, Cerhan JH, Wefel JS, Klein M, Grossman SA, Schiff D, Raizer JJ, Dhermain F, Nordstrom DG, Flynn PJ, Vogelbaum MA. CODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design. Neuro Oncol. 2021 Mar 25; 23 (3):457-467
    View PubMed
  8. Polsinelli AJ, Cerhan JH. Early Cutoff Criteria for Strong Performance on the Test of Memory Malingering. Arch Clin Neuropsychol. 2020 May 22; 35 (4):429-433
    View PubMed
  9. Dubey D, Britton J, McKeon A, Gadoth A, Zekeridou A, Lopez Chiriboga SA, Devine M, Cerhan JH, Dunlay K, Sagen J, Ramberger M, Waters P, Irani SR, Pittock SJ. Randomized Placebo-Controlled Trial of Intravenous Immunoglobulin in Autoimmune LGI1/CASPR2 Epilepsy. Ann Neurol. 2020 Feb; 87 (2):313-323 Epub 2019 Dec 14
    View PubMed
  10. Trifiletti DM, Ballman KV, Brown PD, Anderson SK, Carrero XW, Cerhan JH, Whitton AC, Greenspoon J, Parney IF, Laack NN, Ashman JB, Bahary JP, Hadjipanayis CG, Urbanic JJ, Barker FG 2nd, Farace E, Khuntia D, Giannini C, Buckner JC, Galanis E, Roberge D. Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3). Int J Radiat Oncol Biol Phys. 2020 Feb 1; 106 (2):255-260 Epub 2019 Oct 22
    View PubMed
  11. Cerhan JH, Anderson SK, Butts AM, Porter AB, Jaeckle K, Galanis E, Brown PD. Examiner accuracy in cognitive testing in multisite brain-tumor clinical trials: an analysis from the Alliance for Clinical Trials in Oncology. Neurooncol Pract. 2019 Jul; 6 (4):283-288 Epub 2018 Nov 24
    View PubMed
  12. Cerhan JH, Butts AM, Syrjanen JA, Aakre JA, Brown PD, Petersen RC, Jack CR Jr, Roberts RO. Factors Associated With Meningioma Detected in a Population-Based Sample. Mayo Clin Proc. 2019 Feb; 94 (2):254-261
    View PubMed
  13. Cerhan JH, Caine C, Anderson SK, Johnson DR, Lachance DH, Yan E, Brown PD. Preliminary exploration of a computerized cognitive battery and comparison with traditional testing in patients with high-grade glioma. Neurooncol Pract. 2019 Jan; 6 (1):71-77 Epub 2018 May 21
    View PubMed
  14. Galanis E, Anderson SK, Miller CR, Sarkaria JN, Jaeckle K, Buckner JC, Ligon KL, Ballman KV, Moore DF Jr, Nebozhyn M, Loboda A, Schiff D, Ahluwalia MS, Lee EQ, Gerstner ER, Lesser GJ, Prados M, Grossman SA, Cerhan J, Giannini C, Wen PY, Alliance for Clinical Trials in Oncology and ABTC. Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02. Neuro Oncol. 2018 Mar 27; 20(4):546-556.
    View PubMed
  15. Churilla TM, Ballman KV, Brown PD, Twohy EL, Jaeckle K, Farace E, Cerhan JH, Anderson SK, Carrero XW, Garces YI, Barker FG 2nd, Deming R, Dixon JG, Burri SH, Chung C, Menard C, Stieber VW, Pollock BE, Galanis E, Buckner JC, Asher AL. Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for Limited Brain Metastases: A Secondary Analysis of the North Central Cancer Treatment Group N0574 (Alliance) Randomized Controlled Trial. Int J Radiat Oncol Biol Phys. 2017 Dec 1; 99 (5):1173-1178 Epub 2017 Aug 05
    View PubMed
  16. Brown PD, Ballman KV, Cerhan JH, Anderson SK, Carrero XW, Whitton AC, Greenspoon J, Parney IF, Laack NNI, Ashman JB, Bahary JP, Hadjipanayis CG, Urbanic JJ, Barker FG 2nd, Farace E, Khuntia D, Giannini C, Buckner JC, Galanis E, Roberge D. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC.3): a multicentre, randomised, controlled, phase 3 trial. Lancet Oncol. 2017 Aug; 18 (8):1049-1060 Epub 2017 July 04
    View PubMed
  17. Butts AM, Weigand S, Brown PD, Petersen RC, Jack CR Jr, Machulda MM, Cerhan JH. Neurocognition in individuals with incidentally-identified meningioma. J Neurooncol. 2017 Aug; 134 (1):125-132 Epub 2017 May 25
    View PubMed
  18. Brown PD, Jaeckle K, Ballman KV, Farace E, Cerhan JH, Anderson SK, Carrero XW, Barker FG 2nd, Deming R, Burri SH, Menard C, Chung C, Stieber VW, Pollock BE, Galanis E, Buckner JC, Asher AL. Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial. JAMA. 2016 Jul 26; 316 (4):401-409
    View PubMed
  19. Lageman SK, Brown PD, Anderson SK, Lachance DH, Yan E, Laack NN, Cerhan JH. Exploring primary brain tumor patient and caregiver needs and preferences in brief educational and support opportunities. Support Care Cancer. 2015 Mar; 23 (3):851-9 Epub 2014 Sept 14
    View PubMed
  20. Leise MD, Leung N, El-Zoghby Z, Gonzalez Gonzalez HC, Cerhan JH, Nyberg SL. Treatment of persistent/medically refractory covert hepatic encephalopathy with the molecular adsorbent recirculating system. Liver Transpl 2014 Jul; 20 (7):867-8 Epub 2014 May 26
    View PubMed
  21. Liewluck T, Milone M, Mauermann ML, Castro-Couch M, Cerhan JH, Murthy NS. A novel VCP mutation underlies scapuloperoneal muscular dystrophy and dropped head syndrome featuring lobulated fibers. Muscle Nerve. 2014; 50(2):295-9.
    View PubMed
  22. Dean PM, Cerhan JH. Correction for a potentially biased item on the Mattis Dementia Rating Scale. Am J Alzheimers Dis Other Demen. 2013 Dec; 28(8):734-7. Epub 2013 Oct 01.
    View PubMed
  23. Smith HM, Kopp SL, Johnson RL, Long TR, Cerhan JH, Hebl JR. Looking into learning: visuospatial and psychomotor predictors of ultrasound-guided procedural performance. Reg Anesth Pain Med. 2012 Jul-Aug; 37 (4):441-7
    View PubMed
  24. Caudill JS, Brown PD, Cerhan JH, Rummans TA. Selective serotonin reuptake inhibitors, glioblastoma multiforme, and impact on toxicities and overall survival: the mayo clinic experience. Am J Clin Oncol. 2011 Aug; 34 (4):385-7
    View PubMed
  25. Passov V, Gavrilova RH, Strand E, Cerhan JH, Josephs KA. Sporadic corticobasal syndrome with progranulin mutation presenting as progressive apraxic agraphia. Arch Neurol. 2011 Mar; 68 (3):376-80
    View PubMed
  26. Passov V, Josephs K, Gavrilova RH, Cerhan JH, Strand E. Frontotemporal dementia with progranulin mutation presenting as progressive apraxic dysgraphia. Archives of Neurology. 2011; (In Press).
  27. Lageman SK, Cerhan JH, Locke DE, Anderson SK, Locke DE, Wu W, Brown PD. Comparing neuropsychological tasks to optimize brief cognitive batteries for brain tumor clinical trials. J Neurooncol. 2010 Jan; 96 (2):271-6 Epub 2009 July 19
    View PubMed
  28. Locke DE, Cerhan JH, Wu W, Malec JF, Clark MM, Rummans TA, Brown PD. Cognitive rehabilitation and problem-solving to improve quality of life of patients with primary brain tumors: a pilot study. J Support Oncol. 2008 Nov-Dec; 6 (8):383-91
    View PubMed
  29. Cerhan JH, Ivnik RJ, Smith GE, Machulda MM, Boeve BF, Knopman DS, Petersen RC, Tangalos EG. Alzheimer's disease patients' cognitive status and course years prior to symptom recognition. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2007 May; 14 (3):227-35
    View PubMed
  30. Brown PD, Jensen AW, Felten SJ, Ballman KV, Schaefer PL, Jaeckle KA, Cerhan JH, Buckner JC. Detrimental effects of tumor progression on cognitive function of patients with high-grade glioma. J Clin Oncol. 2006 Dec 1; 24 (34):5427-33
    View PubMed
  31. Stewart CA, Cerhan J. Hepatic encephalopathy: a dynamic or static condition. Metab Brain Dis. 2005 Sep; 20 (3):193-204
    View PubMed
  32. Poirier MK, Clark MM, Cerhan JH, Pruthi S, Geda YE, Dale LC. Teaching motivational interviewing to first-year medical students to improve counseling skills in health behavior change. Mayo Clin Proc. 2004 Mar; 79(3):327-31.
    View PubMed
  33. Cerhan JH, Ivnik RJ, Smith GE, Tangalos EC, Petersen RC, Boeve BF. Diagnostic utility of letter fluency, category fluency, and fluency difference scores in Alzheimer's disease. Clin Neuropsychol. 2002 Feb; 16 (1):35-42
    View PubMed
  34. Ivnik RJ, Smith GE, Cerhan JH, Boeve BF, Tangalos EG, Petersen RC. Understanding the diagnostic capabilities of cognitive tests. Clin Neuropsychol. 2001 Feb; 15 (1):114-24
    View PubMed
  35. Cerhan JH. The Hmong in the United States: An overview for mental health professionals. Journal of Counseling & Development. 1990; 69:88-92.
  36. Ugland JH. Health as a value: Implications for practice. Professional Psychology: Research and Practice.. 1989; 20: 415-16.
PST-20218153